- Home
- COLB vs ABVX Comparison
COLB vs ABVX Comparison
Compare COLB & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLB
- ABVX
- Stock Information
- Founded
- COLB 1993
- ABVX 2013
- Country
- COLB United States
- ABVX France
- Employees
- COLB N/A
- ABVX N/A
- Industry
- COLB Major Banks
- ABVX
- Sector
- COLB Finance
- ABVX
- Exchange
- COLB Nasdaq
- ABVX Nasdaq
- Market Cap
- COLB 5.4B
- ABVX 5.3B
- IPO Year
- COLB N/A
- ABVX N/A
- Fundamental
- Price
- COLB $26.90
- ABVX $88.03
- Analyst Decision
- COLB Hold
- ABVX Buy
- Analyst Count
- COLB 15
- ABVX 7
- Target Price
- COLB $28.87
- ABVX $74.86
- AVG Volume (30 Days)
- COLB 4.8M
- ABVX 1.1M
- Earning Date
- COLB 10-30-2025
- ABVX 08-11-2025
- Dividend Yield
- COLB 5.31%
- ABVX N/A
- EPS Growth
- COLB 10.98
- ABVX N/A
- EPS
- COLB 2.52
- ABVX N/A
- Revenue
- COLB $1,871,957,000.00
- ABVX $11,444,012.00
- Revenue This Year
- COLB $22.95
- ABVX $25.23
- Revenue Next Year
- COLB $30.02
- ABVX N/A
- P/E Ratio
- COLB $10.76
- ABVX N/A
- Revenue Growth
- COLB 1.23
- ABVX 128.98
- 52 Week Low
- COLB $19.61
- ABVX $4.77
- 52 Week High
- COLB $32.85
- ABVX $92.91
- Technical
- Relative Strength Index (RSI)
- COLB 61.25
- ABVX 86.74
- Support Level
- COLB $26.27
- ABVX $78.00
- Resistance Level
- COLB $27.52
- ABVX $78.49
- Average True Range (ATR)
- COLB 0.61
- ABVX 3.31
- MACD
- COLB 0.00
- ABVX -0.56
- Stochastic Oscillator
- COLB 74.06
- ABVX 81.06
About COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.